Skip to main content
SpringerLink
Log in
Book cover

Pediatric Mental Health for Primary Care Providers pp 145–159Cite as

Attention-Deficit/Hyperactivity Disorder

  • Chapter
  • First Online:

  • 691 Accesses

Abstract

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by impairments in focus and self-control. It is one of the most commonly seen and treated psychiatric disorders in the pediatric primary care setting. This chapter describes the signs, symptoms, and impact of ADHD. It walks clinicians through the diagnostic process and prompts them to consider other psychiatric disorders with similar presentations. Medications, behavioral strategies, and indications for a mental health referral are reviewed. This chapter closes with tips and resources for parents of children with ADHD.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Biederman J, Petty CR, Clarke A, Lomedico A, Faraone SV. Predictors of persistent ADHD: an 11-year follow-up study. J Psychiatr Res. 2011;45:150–5.

    Article  Google Scholar 

  2. Frazier TW, Youngstrom EA, Glutting JJ, Watkins MW. ADHD and achievement: meta-analysis of the child, adolescent, and adult literatures and a concomitant study with college students. J Learn Disabil. 2007;40:49–65.

    Article  Google Scholar 

  3. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164:942–8.

    Article  Google Scholar 

  4. Banaschewski T, Becker K, Döpfner M, Holtmann M, Rösler M, Romanos M. Attention-deficit/hyperactivity disorder. Dtsch Arztebl Int. 2017;114:149–59.

    PubMed  PubMed Central  Google Scholar 

  5. Pliszka S. Attention-deficit/hyperactivity disorder. In: Dulcan M, editor. Dulcan’s textbook of adolescent psychiatry. Washington: American Psychiatric Association Publishing; 2016. p. 513–72.

    Google Scholar 

  6. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 2013.

    Google Scholar 

  7. Çak HT, Çengel Kültür SE, Gökler B, Öktem F, Taşkıran C. The behavior rating inventory of executive function and continuous performance test in preschoolers with attention deficit hyperactivity disorder. Psychiatry Investig. 2017;14:260–70.

    Article  Google Scholar 

  8. Mohr-Jensen C, Steinhausen HC. A meta-analysis and systematic review of the risks associated with childhood attention-deficit hyperactivity disorder on long-term outcome of arrests, convictions, and incarcerations. Clin Psychol Rev. 2016;48:32–42.

    Article  Google Scholar 

  9. Erskine HE, Norman RE, Ferrari AJ, et al. Long-term outcomes of attention-deficit/hyperactivity disorder and conduct disorder: a systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2016;55:841–50.

    Article  Google Scholar 

  10. Tung I, Li JJ, Meza JI, et al. Patterns of comorbidity among girls with adhd: a meta-analysis. Pediatrics. 2016;138.

    Google Scholar 

  11. Yoshimasu K, Barbaresi WJ, Colligan RC, et al. Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population-based birth cohort study. J Child Psychol Psychiatry. 2012;53:1036–43.

    Article  Google Scholar 

  12. Zwi M, Jones H, Thorgaard C, York A, Dennis JA. Parent training interventions for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years. Cochrane Database Syst Rev. 2011;12:CD003018.

    Google Scholar 

  13. Fabiano GA, Schatz NK, Aloe AM, Chacko A, Chronis-Tuscano A. A systematic review of meta-analyses of psychosocial treatment for attention-deficit/hyperactivity disorder. Clin Child Fam Psychol Rev. 2015;18:77–97.

    Article  Google Scholar 

  14. Blum NJ, Jawad AF, Clarke AT, Power TJ. Effect of osmotic-release oral system methylphenidate on different domains of attention and executive functioning in children with attention-deficit-hyperactivity disorder. Dev Med Child Neurol. 2011;53:843–9.

    Article  Google Scholar 

  15. Rhodes SM, Coghill DR, Matthews K. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains. J Child Psychol Psychiatry. 2006;47:1184–94.

    Article  Google Scholar 

  16. Swanson JM, Hechtman L. Using long-acting stimulants: does it change ADHD treatment outcome. Can Child Adolesc Psychiatr Rev. 2005;14:2–3.

    PubMed  PubMed Central  Google Scholar 

  17. Watkins C. Stimulant Medication and AD/HD. 20061.

    Google Scholar 

  18. Cascade E, Kalali AH, Wigal SB. Real-world data on: attention deficit hyperactivity disorder medication side effects. Psychiatry (Edgmont). 2010;7:13–5.

    Google Scholar 

  19. Cherland E, Fitzpatrick R. Psychotic side effects of psychostimulants: a 5-year review. Can J Psychiatr. 1999;44:811–3.

    Article  CAS  Google Scholar 

  20. Stahl S. Methylphenidate (D,L). Prescriber’s guide. New York, NY: Cambridge University Press; 2014. p. 417–23.

    Google Scholar 

  21. Swanson JM, Elliott GR, Greenhill LL, et al. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry. 2007;46:1015–27.

    Article  Google Scholar 

  22. Harstad EB, Weaver AL, Katusic SK, et al. ADHD, stimulant treatment, and growth: a longitudinal study. Pediatrics. 2014;134(4):e935–44. https://doi.org/10.1542/peds.2014-0428.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Brown RT, Wynne ME, Slimmer LW. Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning. J Clin Psychiatry. 1984;45:473–6.

    CAS  PubMed  Google Scholar 

  24. Silva RR, Skimming JW, Muniz R. Cardiovascular safety of stimulant medications for pediatric attention-deficit hyperactivity disorder. Clin Pediatr (Phila). 2010;49:840–51.

    Article  Google Scholar 

  25. Chayer R. Basic principles in the pharmacologic management of ADHD. 2013;Sect. 1.

    Google Scholar 

  26. Johnston LD, O’Malley PM, Miech RA, Bachman JG, Schulenberg JE. Monitoring the future national survey results on drug use, 1975–2016: overview, key findings on adolescent drug use. Ann Arbor: Institute for Social Research, The University of Michigan; 2017.

    Google Scholar 

  27. Quinn PD, Chang Z, Hur K, et al. ADHD medication and substance-related problems. Am J Psychiatry. 2017;174:877–85.

    Article  Google Scholar 

  28. Shannon S. Integrative approach to attention deficit hyperactivity disorder. The Carlat Report Child Psychiatry. 2017:1–10.

    Google Scholar 

  29. Newcorn JH, Clerkin S, Schulz K, Halperin J. Clonidine and guanfacine. In: Martin A, Scahill L, Kratochvil C, editors. Pediatric psychopharmacology. New York City: Oxford University Press; 2011. p. 263–74.

    Google Scholar 

  30. Wang Y, Zheng Y, Du Y, et al. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. Aust N Z J Psychiatry. 2007;41:222–30.

    Article  CAS  Google Scholar 

  31. Hanwella R, Senanayake M, de Silva V. Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis. BMC Psychiatry. 2011;11:176.

    Article  CAS  Google Scholar 

  32. Liu Q, Zhang H, Fang Q, Qin L. Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: meta-analysis based on head-to-head trials. J Clin Exp Neuropsychol. 2017;39:854–65.

    Article  Google Scholar 

  33. Ng QX. A systematic review of the use of bupropion for attention-deficit/hyperactivity disorder in children and adolescents. J Child Adolesc Psychopharmacol. 2017;27:112–6.

    Article  CAS  Google Scholar 

  34. Verbeeck W, Bekkering GE, Van den Noortgate W, Kramers C. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2017;10:CD009504.

    PubMed  Google Scholar 

  35. Psychiatry AAOCAA. When to Seek Referral or Consultation with a CAP.

    Google Scholar 

  36. Daughton J, Kratochvil C. Stimulants. In: Martin A, Scahill L, Kratochvil C, editors. Pediatric psychopharmacology. New York: Oxford University Press; 2011. p. 251–62.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lorio Psych Group, Atlanta, GA, USA

    Hasani Baharanyi

  2. Morehouse School of Medicine Adjunct Faculty, Atlanta, GA, USA

    Hasani Baharanyi

Authors
  1. Hasani Baharanyi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hasani Baharanyi .

Editor information

Editors and Affiliations

  1. Lorio Psych Group, Atlanta, GA, USA

    Sarah Y. Vinson

  2. Lorio Psych Group, Atlanta, GA, USA

    Ebony S. Vinson

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Baharanyi, H. (2018). Attention-Deficit/Hyperactivity Disorder. In: Vinson, S., Vinson, E. (eds) Pediatric Mental Health for Primary Care Providers. Springer, Cham. https://doi.org/10.1007/978-3-319-90350-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90350-7_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90349-1

  • Online ISBN: 978-3-319-90350-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation